Qatar Investment Authority in Nanobiotix S.A.
Completed. First disclosed November 8, 2023, in a Schedule 13G (source).
- Investor
- Qatar Investment Authority (Qatar)
- Target
- Nanobiotix S.A. (EDGAR CIK 1760854)
- Target country
- France
- Sector
- Health and Life Sciences (SIC 2834)
- First disclosed
- November 8, 2023, Schedule 13G
- Amount
- Not stated
- Stake at first disclosure
- 8.6%
- Latest stated stake
- 7.0% (July 29, 2026)
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| November 8, 2023 | Schedule 13G | 8.6% | View |
| February 8, 2024 | Schedule 13G/A | 9.1% | View |
| July 29, 2026 | Schedule 13G/A | 7.0% | View |
Cite: Middle East Forum, “Qatar Investment Authority in Nanobiotix S.A.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/qia-nanobiotix-s-a-1760854/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.